Glucagon‐like peptide‐1 agonists combined with sodium‐glucose cotransporter‐2 inhibitors reduce weight in type 1 diabetes

Ebaa Al‐Ozairi, Mohammad Irshad, Etab Taghadom, Litty Sojan, Jumana Al Kandari, Dherar Alroudhan, Carel W. le Roux

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
24 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Glucagon‐like peptide‐1 agonists combined with sodium‐glucose cotransporter‐2 inhibitors reduce weight in type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences